These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2822052)

  • 1. Meclofenamate sodium monohydrate inhibits chemotactic factor-induced human polymorphonuclear leukocyte function. A possible explanation for its antiinflammatory effect.
    Perez HD; Elfman F; Marder S
    Arthritis Rheum; 1987 Sep; 30(9):1023-31. PubMed ID: 2822052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of non-steroidal anti-inflammatory drugs on isolated human polymorphonuclear leukocytes (PMN): chemotaxis, superoxide production, degranulation and N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP) receptor binding.
    Shelly J; Hoff SF
    Gen Pharmacol; 1989; 20(3):329-34. PubMed ID: 2545509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolfenamic acid inhibits leukotriene B4-induced chemotaxis of polymorphonuclear leukocytes in vitro.
    Kankaanranta H; Moilanen E; Vapaatalo H
    Inflammation; 1991 Apr; 15(2):137-43. PubMed ID: 1649132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of diclofenac sodium, tolfenamic acid and indomethacin on the production of superoxide induced by N-formyl-methionyl-leucyl-phenylalanine in normal human polymorphonuclear leukocytes.
    Friman C; Johnston C; Chew C; Davis P
    Scand J Rheumatol; 1986; 15(1):41-6. PubMed ID: 3008321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of in vitro neutrophil responses to chemotactic factors by piroxicam.
    Tanaka K; Kanaoka K; Egawa M; Abe N; Watanabe I; Hirai S
    Jpn J Pharmacol; 1984 Jun; 35(2):181-91. PubMed ID: 6611436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotactic peptide from ropalidian wasp as well as the authentic chemotactic tripeptide stimulates two distinct pathways in neutrophils, but the [LYS7] analog does only one of them.
    Koike M; Nagashima K; Saito K; Nakanishi M; Fujino M; Nakajima T
    Biochem Biophys Res Commun; 1991 Feb; 175(1):165-72. PubMed ID: 1847803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions.
    Webster RO; Goldstein IM; Flick MR
    J Lab Clin Med; 1984 Jan; 103(1):22-33. PubMed ID: 6317777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of ibuprofen and methylprednisolone on chemotactic factor-induced transcutaneous hypoxia.
    Maderazo EG; Breaux SP; Woronick CL
    J Pharmacol Exp Ther; 1986 Aug; 238(2):453-6. PubMed ID: 3735126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of non-steroidal anti-inflammatory drugs on polymorphonuclear leukocyte functions in vitro: focus on fenamates.
    Kankaanranta H; Moilanen E; Vapaatalo H
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Dec; 350(6):685-91. PubMed ID: 7708126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the anti-inflammatory compound flosulide on granulocyte function.
    Zimmerli W; Sansano S; Wiesenberg-Böttcher I
    Biochem Pharmacol; 1991 Oct; 42(10):1913-9. PubMed ID: 1660271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
    Perez HD; Elfman F; Chenoweth D; Hooper C
    J Immunol; 1986 Mar; 136(5):1813-9. PubMed ID: 3753994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hirudin on the chemotactic properties of alpha-thrombin.
    Morin A; Marchand-Arvier M; Doutremepuich C; Vigneron C
    Haemostasis; 1991; 21 Suppl 1():32-5. PubMed ID: 1894195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphotericin B alters the affinity and functional activity of the oligopeptide chemotactic factor receptor on human polymorphonuclear leukocytes.
    Lohr KM; Snyderman R
    J Immunol; 1982 Oct; 129(4):1594-9. PubMed ID: 6286769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human polymorphonuclear leukocyte function by 2-cyclohexene-1-one. A role for glutathione in cell activation.
    Wedner HJ; Simchowitz L; Stenson WF; Fischman CM
    J Clin Invest; 1981 Aug; 68(2):535-43. PubMed ID: 6267107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotactic factor-induced generation of superoxide radicals by human neutrophils: effect of metabolic inhibitors and antiinflammatory drugs.
    Simchowitz L; Mehta J; Spilberg I
    Arthritis Rheum; 1979 Jul; 22(7):755-63. PubMed ID: 222300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a cyclooxygenase inhibitor on the in vivo polymorphonuclear leukocyte migration to Pseudomonas aeruginosa peptide chemotactins.
    Fontán PA; Amura CR; Sordelli DO
    Agents Actions; 1993 Sep; 40(1-2):106-9. PubMed ID: 8147264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolfenamic acid and leukotriene synthesis inhibition.
    Moilanen E; Kankaanranta H
    Pharmacol Toxicol; 1994; 75 Suppl 2():60-3. PubMed ID: 7816785
    [No Abstract]   [Full Text] [Related]  

  • 18. Chlorpromazine inhibits neutrophil chemotaxis beyond the chemotactic receptor-ligand interaction.
    Lohr KM; Feix JB; Kurth C
    J Infect Dis; 1984 Nov; 150(5):643-52. PubMed ID: 6092486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of some human neutrophil functions by the cyclooxygenase inhibitor ketorolac tromethamine.
    Hyers TM; Tricomi SM; Liao JJ
    J Leukoc Biol; 1992 May; 51(5):490-5. PubMed ID: 1318350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vitro effects of flunixin and tolfenamic acid on human leukocyte and platelet functions.
    Kankaanranta H; Moilanen E; Vapaatalo H
    Inflammation; 1993 Aug; 17(4):417-25. PubMed ID: 8406686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.